Krabeva 100mg Bevacizumab Injection

Krabeva 100mg Bevacizumab Injection is a prescription anti-cancer medication containing Bevacizumab, a targeted therapy used to treat several types of cancer, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It works by inhibiting vascular endothelial growth factor (VEGF), a protein that promotes the growth of blood vessels supplying tumors. By restricting this blood supply, Krabeva 100mg Bevacizumab Injection helps slow tumor growth and spread. Administered as an intravenous infusion under the supervision of an oncology specialist, it is often used alongside chemotherapy or other cancer treatments. Regular medical monitoring is essential during treatment to manage potential side effects and ensure optimal therapeutic outcomes. Patients should always follow their healthcare provider’s instructions for the safe and effective use of Krabeva 100mg Injection.